Detalhe da pesquisa
1.
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.
Cell
; 173(3): 624-633.e8, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656892
2.
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Cell
; 175(4): 984-997.e24, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388455
3.
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
Proc Natl Acad Sci U S A
; 118(43)2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670835
4.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099927
5.
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.
J Eur Acad Dermatol Venereol
; 37(5): 884-893, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433671
6.
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.
Eur Arch Otorhinolaryngol
; 280(9): 4215-4223, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272953
7.
Extending the Mass Spectrometry-Detectable Landscape of MHC Peptides by Use of Restricted Access Material.
Anal Chem
; 94(41): 14214-14222, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194871
8.
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Nature
; 532(7598): 250-4, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042933
9.
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 395(10236): 1558-1568, 2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416781
10.
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma.
Cancer Immunol Immunother
; 70(7): 2087-2093, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439294
11.
Aberrant cytoplasmic connexin43 expression as a helpful marker in vascular neoplasms.
J Cutan Pathol
; 48(11): 1335-1341, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021619
12.
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.
J Med Internet Res
; 23(7): e20708, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255646
13.
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase.
Acta Derm Venereol
; 100(13): adv00174, 2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449784
14.
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study.
J Med Internet Res
; 22(9): e18091, 2020 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915161
15.
COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
J Dtsch Dermatol Ges
; 18(8): 795-807, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761894
16.
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
Cancer
; 125(4): 586-600, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561760
17.
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
Cancer Immunol Immunother
; 68(5): 765-772, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30806748
18.
Patients' and dermatologists' preferences in AI-driven skin cancer diagnostics: prospective multicentric survey study.
J Am Acad Dermatol
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670313
19.
Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning.
J Am Acad Dermatol
; 90(5): 1028-1031, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199280
20.
Nonsense-Mutation in SUFU ist mit multiplen infundibulozystischen Basalzellkarzinomen assoziiert: A nonsense mutation in SUFU associated with multiple infundibulocystic basal cell carcinomas.
J Dtsch Dermatol Ges
; 21(11): 1396-1398, 2023 11.
Artigo
em Alemão
| MEDLINE | ID: mdl-37946635